Skip to main content

Valeria Tubita

Institutions of which they are part

Main researcher
Biomedical Research in Gynaecology
Vall Hebron Institut de Recerca

Valeria Tubita

Institutions of which they are part

Main researcher
Biomedical Research in Gynaecology
Vall Hebron Institut de Recerca

Projects

Búsqueda de firmas proteómicas y dianas terapéuticas en el cáncer de ovario seroso de alto grado avanzado resistente a platino

IP: Antonio Gil Moreno
Collaborators: Vicente Bebia Conesa, Francesc Xavier Serra Marin, Marta Rebull Santamaria, Martina Angeles Fite, Ana Luzarraga Aznar, Melissa Bradbury Lobato, Beatriz Villafranca Magdalena, Melek Denizli, Lourdes Elena Salazar Huayna, Giulio Bonaldo, Lourdes Elena Salazar Huayna, Valeria Tubita
Funding agency: Instituto de Salud Carlos III
Funding: 196250
Reference: PI24/01509
Duration: 01/01/2025 - 31/12/2027

Related news

The Department of Health of the Generalitat de Catalunya grants subsidies for carrying out validation tests on innovative projects in the field of health that are in the early stages of development.

On World Cancer Research Day, we highlight research aimed at improving treatments for both pediatric and adult cancers through innovative techniques.

From 6th to 7th March, more than 60 European researchers have shared the advances in translational research in endometrial cancer

Related professionals

Enric Pàmies Barcons

Enric Pàmies Barcons

Transfusional Medicine
Read more
Veronica Fernández Angulo

Veronica Fernández Angulo

Multidisciplinary Nursing Research Group
Read more
JACINTO BAENA CAPARROS

JACINTO BAENA CAPARROS

Neurotraumatology and Neurosurgery Research Unit (UNINN)
Read more
Margareta Anna Clarke

Margareta Anna Clarke

Research technician
Neuroradiology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.